| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Metagenomi Therapeutics, Inc. (MGX) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. MGX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.51M | $3.05M | - | |
| Other | 377.5K | $458.7K | -3,737 | |
| CFO | 208.5K | $253.3K | -2,884 | |
| Other | 126.5K | $153.7K | -558 | |
| Dir | 21.0K | $25.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2024 | Novo Holdings A/s58 | 10% Owner | Buy | 900,000 | $14.47 | $13,025,000.00 | +95.8% | -44.0% | -79.6% |